Effects of sorbinil treatment in rats with chronic streptozotocin-diabetes; changes in lens and in substance P and catecholamines in the iris

Abstract

This study was performed on male Wistar rats with streptozotocin-induced diabetes mellitus of 11 months duration. There were two diabetic groups; both were given a long-acting insulin twice weekly to reduce morbidity. One group received no additional treatment whilst the other was given the aldose reductase inhibitor, sorbinil, by dietary admixture (approximate dose was 30 mg/day/kg body weight). At the end of the protocol the lenses of the diabetic rats giver insulin alone showed markedly reduced dry weight (70% of controls; p<0.01) with increased water content (152% of controls; p<0.01). Both of these changes were absent from the lenses of the sorbinil-treated diabetic rats. Lenses from both groups of diabetic rats had elevated glucose contents, with greater levels in the group which received insulin alone. Polyol pathway metabolites were also raised in the diabetic lenses, though sorbinil treatment had markedly attenuated sorbitol accumulation without affecting fructose levels. Lens myo-inositol was almost absent from the diabetic rats whicl received only insulin (6% of control levels relative to lens dry weight; p<0.01). This depletion was substantially attenuated, but not prevented in the sorbinil-treated group (58% of control levels). In the iris the noradrenaline and adrenaline contents were unaltered in eithei diabetic group. In startling contrast, the iris content of substance P-like immunoreactivity was almost trebled in the insulin alone-treatec diabetic rats (282% of controls; p<0.01), an effect which was prevented completely by sorbinil (127% of controls; not significantly different). These marked differences in the iris substance 1 content of the two diabetic groups occurrec against a background of similar levels of the peptide immunoreactivity in the trigeminal ganglion, the site of the cell bodies of the neurones supplying substance P to the iris.